Chris Spivey - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Chris Spivey's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Chris Spivey
Verified
Editorial Director, BioPharm International
Beats
Stocks and bond markets.
Content
By Chris Spivey Verified, Philip R. Dormitzer, Phil Felgner, Jeffrey B. Ulmer, Andy Geall| BioPharm International Verified The pivotal paper series brings to a wider audience a sharp focus on important advances in the biomedical field. This particular paper comes at a troubling time in the vaccine industry, which is currently beset by misinformation and disinformation.
By Chris Spivey Verified| BioPharm International Verified With a focus on improving drug delivery, David Fairen-Jimenez, PhD, and his company, Vector Bioscience Cambridge, have carved out their corner of precision medicine with their platform that utilizes high-porosity nanomaterials to deliver targeted treatments with less toxicity.
By Chris Spivey Verified, Philip R. Dormitzer, Phil Felgner, Jeffrey B. Ulmer, Andy Geall| BioPharm International Verified The pivotal paper series brings to a wider audience a sharp focus on important advances in the biomedical field. This particular paper comes at a troubling time in the vaccine industry, which is currently beset by misinformation and disinformation.
Company Info
BioPharm International
BioPharm International is a prominent publication dedicated to the biopharmaceutical industry, providing a blend of scientific and business insights. It serves as an independent source for technical solutions and industry news, covering various aspects of research, development, and manufacturing. The company offers a monthly print magazine, daily online updates, newsletters, ebooks, webcasts, and special issues to keep professionals informed. The services provided by BioPharm International include peer-reviewed technical articles that assist biopharmaceutical professionals in their work, as well as insights into business strategies and regulatory matters. Additionally, the company offers marketing and advertising options to connect with its audience, including print and digital advertising, newsletter placements, and custom programs. With an annual revenue of $17 million and a dedicated team, BioPharm International plays a vital role in the biopharmaceutical publishing sector.
'+1 609-716-7777
Founded: 2011